Early 2017 the platform has been revised and expanded, to allow detection of mutations in de TERT promoter, in genes important for pediatric brain tumors and other adult non-glioma brain tumors and more CNA’s (including 9p, 17) that are relevant for pediatric, adolescents and young adults. The gene discussed is TERT; the disease is central nervous system cancer.